secwatch.observer — SEC 8-K summary
======================================

Issuer:     Personalis, Inc. (PSNL)
CIK:        0001527753
Form:       8-K
Filed at:   2024-08-16T23:59:59+00:00
Accession:  0001193125-24-201697
Event type: other_material
Sentiment:  positive
Materiality: 0.75
Item codes: 1.01, 3.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Tempus invests $36M in Personalis, exercises warrants and buys shares; expands commercial collaboration
--------------------------------------------------------------------------------

- Tempus exercises warrants for 9.2M shares at avg $2.00 ($18.4M) and buys 3.5M shares at $5.07 ($17.7M).
- Total investment ~$36M; Tempus will own ~19.3% of Personalis outstanding common stock.
- Partners accelerate commercialization of ultra-sensitive MRD testing for breast, lung, and immunotherapy monitoring.
- Personalis to increase patient sample capacity; Tempus expands commercialization efforts over first two years.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1527753/000119312524201697/0001193125-24-201697-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1527753/000119312524201697/d836724d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-201697

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer